---
title: "US FDA approval for AI-powered left ejection fraction detection device"
date: "2023-10-02T13:50:53.000Z"
publishedDate: "2 octobre 2023"
summary: "Anumana has announced US Food and Drug Administration (FDA) 510(k) clearance for ECG-AI LEF, a breakthrough artificial intelligence (AI)-powered medical device to detect low ejection fraction (LEF) in patients at risk of heart failure. “Anumana’s ECG-AI LEF fills an important unmet need—the lack of an easily accessible point-of-care, non-invasive, and inexpensive tool to screen for [&#8230;] The post US FDA approval for AI-powered left ejection fraction detection device appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/anumana-us-fda-approval/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-10-02-us-fda-approval-for-ai-powered-left-ejection-fraction-detection-device"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/08/digital-code.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/anumana-us-fda-approval/"
---

![US FDA approval for AI-powered left ejection fraction detection device](https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/08/digital-code.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/anumana-us-fda-approval/*

## L’essentiel

Anumana has announced US Food and Drug Administration (FDA) 510(k) clearance for ECG-AI LEF, a breakthrough artificial intelligence (AI)-powered medical device to detect low ejection fraction (LEF) in patients at risk of heart failure. “Anumana’s ECG-AI LEF fills an important unmet need—the lack of an easily accessible point-of-care, non-invasive, and inexpensive tool to screen for [&#8230;] The post US FDA approval for AI-powered left ejection fraction detection device appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/anumana-us-fda-approval/
